Search results
FDA Approves Moderna’s mRESVIA Vaccine | JD Supra
JD Supra· 1 day agoOn May 31, 2024, Moderna announced that the FDA has approved its respiratory syncytial virus vaccine (“RSV”), mRESVIA (mRNA-1345). The vaccine...
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 5 days agoModerna has secured approval from the US Food and Drug Administration (FDA) for its mRNA-based respiratory syncytial virus (RSV) vaccine mRESVIA...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 5 days agoModerna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company presented the latest...
Artificial lymph nodes teaches T cells to kill cancer
Futurity· 22 hours agoScientists have developed an artificial lymph node with the potential to treat cancer, according to...
The new technology inside COVID-19 vaccines— mRNA
KRGV Rio Grande Valley· 6 days agoWhen you think of vaccines, you may think about traditional vaccines with weak or inactive parts of a virus to trigger an immune response. Today...
ESHG: Neoantigen Vaccine Helps Prevent Cancer in Lynch Syndrome Patients
GenomeWeb News· 4 days agoA neoantigen vaccine was able to prevent cancer in a subset of Lynch syndrome patients who mounted a T-cell response to one of the neoantigens, increasing ...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 1 day agoModerna also just gained approval for its RSV vaccine. Pfizer also won FDA approval for Beqvez, its...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 5 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
Penn Medicine Develops Potent mRNA Vaccine Against Lethal H5N1 Virus
SciTechDaily· 7 days agoExperimental mRNA vaccine proves highly effective against H5N1 in animal studies, offering hope for...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 5 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
